Your search for cardiovascular disease returned 979 results

There is an unmet need for cardiovascular disease prevention measures for patients with inflammatory joint diseases.

Patients with rheumatoid arthritis have an increased risk of developing cardiovascular disease (CVD) and CVD-related mortality compared with the general population. Despite the growing recognition of CVD as a common complication of RA, many rheumatologists do not aggressively manage CV risk in patients with rheumatic disease.

The authors reviewed the effects of urate-lowering therapy on cardiovascular disease in patients with gout.

The relationship between atherosclerotic cardiovascular disease (CVD) and rheumatoid arthritis (RA) is detailed.

Vigorous physical activity is associated with reduced mortality, and lower rates of cardiovascular disease.

Researchers examined the incidence, inflammatory correlates, and consequences of persisting pain symptoms in individuals with long COVID.

The presence of tophi in people with gout was associated with increased risk for cardiovascular disease.

Investigators aimed to determine whether long-term rheumatoid arthritis severity is associated with multimorbidity patterns.

DMARD therapy for rheumatoid arthritis (RA) treatment also cuts cardiovascular disease risk.

Investigators sought to assess cardiorespiratory fitness among young people with juvenile idiopathic arthritis compared with healthy patients.

Researchers investigated the associations between artificial sweeteners from all dietary sources and the risk for cardiovascular diseases.

Researchers assessed the prevalence and incidence rate of cardiovascular morbidity in patients with inflammatory arthritis and determined whether the coexistence of multiple autoimmune disorders was associated with increased risk for cardiovascular disease.

Optimal management of cardiovascular disease (CVD) risk factors continues to be a key objective of CVD risk management in patients with RA.

Inverse association seen for mortality from all cardiovascular disease, ischemic heart disease, stroke

A study was done to examine the relationship between social isolation and cardiovascular disease in postmenopausal women.

Subclinical cardiovascular disease (CVD) appears to be an independent risk factor for falls in older adults.

Adults between 40 and 75 years of age without a history of CVD should use a low- to moderate-dose statin to prevent CVD events.

Tamara Horwich, MD, Eugenia Gianos, MD, and Kenneth Fleisher, DDS, reflect on the link between cardiovascular disease and oral health.

For individuals with or without hypertension, initiation of sodium-containing acetaminophen is associated with an increased risk for cardiovascular disease.

Nonsteroidal anti-inflammatory drug use mediated a substantial amount of cardiovascular disease risk in osteoarthritis.

Women with systemic lupus erythematosus and depression were more likely to have increased carotid intima-media thickness compared with those with SLE without depression.

Improved treatment in SLE with increased life expectancy has been accompanied by an elevated risk for developing cardiovascular diseases.

Genetic evidence indicates that hypertensive disorders of pregnancy are associated with an increased risk for atherosclerotic cardiovascular disease.

Intake of all types of coffee is associated with reduced incident cardiovascular disease and all-cause mortality.

A study of patients at a community-based nephrology practice found a higher cardiovascular disease prevalence with hyperuricemia or gout.

The USPSTF recommends against the use of beta carotene or vitamin E for prevention of cardiovascular disease or cancer.

Evidence supports a causal association between radiation exposure and cardiovascular disease, although there is interstudy heterogeneity.

Individuals with prenatal depression have an increased risk for a new cardiovascular disease (CVD) diagnosis.

CTD is associated with higher prevalence of atherosclerotic cardiovascular disease in African Americans and in young adults.

A comprehensive meta-analysis quantified the risks of several cardiovascular diseases in patients with systemic lupus erythematosus (SLE).